ALSTOM : UBS gives a Neutral rating
Published on 05/14/2025 at 09:50
Share
UBS's research confirms his advice and maintains his neutral opinion on the stock. The target price remains set at EUR 20.
Share
© MarketScreener with dpa-AFX Analyser - 2025